Mersana Therapeutics SG&A Expense (Quarterly) Insights

Mersana Therapeutics Inc (MRSN)

2.47 -0.10 (-3.89%) USD | NASDAQ | May 23, 16:00

2.47 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	11.56M
December 31, 2023	10.13M
September 30, 2023	12.89M
June 30, 2023	18.19M
March 31, 2023	18.33M
December 31, 2022	14.80M
September 30, 2022	14.57M
June 30, 2022	14.80M
March 31, 2022	12.78M
December 31, 2021	10.67M
September 30, 2021	10.12M
June 30, 2021	8.883M
March 31, 2021	7.208M
December 31, 2020	5.914M
September 30, 2020	5.881M
June 30, 2020	5.171M
March 31, 2020	4.936M

Date	Value
December 31, 2019	4.211M
September 30, 2019	4.436M
June 30, 2019	4.192M
March 31, 2019	4.443M
December 31, 2018	4.153M
September 30, 2018	4.38M
June 30, 2018	4.231M
March 31, 2018	3.571M
December 31, 2017	3.056M
September 30, 2017	2.905M
June 30, 2017	2.204M
March 31, 2017	2.296M
December 31, 2016	1.94M
September 30, 2016	1.598M
June 30, 2016	1.826M
March 31, 2016	1.621M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

4.192M

Minimum

Jun 2019

18.33M

Maximum

Mar 2023

9.985M

Average

10.13M

Median

SG&A Expense (Quarterly) Benchmarks